About US
Contact us
-
ILE Stand Design Drawing on CPhI China 2013ILE Pharmaceutical Materials Co. sincerely invites you to visit CPhI, ICSE & BiDate: June 25th– 27th, 2013 Address: Shanghai New International Expo Center ( No. 2345 Longyang Road, Pudong District2013/6/19
-
AstraZeneca homes in on new HQ and research site in CambridgeAstraZeneca's new CEO has zeroed in on a site for its new headquarters and R&D center in the U.K. Over the next three years the pharma company ($AZN) plans to build a $500 million complex on an 112013/6/19
-
Newly minted Sanofi diabetes med fails to impress German pricing regulatorsSanofi's ($SNY) newdiabetesdrug has hit a setback in Germany. The country's increasingly strict pricing regulators say Lyxumia delivers "no additional benefit" compared with existing drugs. If the dec2013/6/18
-
FDA probes long-acting Zyprexa safety after 2 patients dieTwo patients have died unexpectedly after their Zyprexa Relprevv injections, and the FDA is now investigating. The agency says the patients died three to four days after receiving "an appropriate dose2013/6/18
-
Elan goes on the block in the final hour of takeover fightElanis officially up for sale. Seeking to dodge a hostile takeover bid fromRoyalty Pharma, the Irish company said Friday morning that it has begun a formal sales process,Reutersreports, and invited Ro2013/6/17
-
Wockhardt gets kicked in the gut againThere is more financially painful news for India'sWockhardt. India has banned the sale of painkiller dextropropoxyphene, and Wockhardt's branded version, Proxyvon, made up about 4% of its sales. That2013/6/17
-
Credit Suisse says Pfizer patent win will discourage 'at-risk' launchesWill Pfizer's ($PFE) big patent win against Teva Pharmaceutical Industries ($TEVA) and India'sSun PharmaonProtonixdiscourage more "at-risk" drug launches of generics in the U.S.? Credit Suisse thinks2013/6/14
-
UPDATED: GSK probes sales tactics in China days after firing R&D chief thereSales scandals are breaking out around the world for Big Pharma. Novartis ($NVS) acknowledged this week it had terminated some sales execs in India as it probes unethical practices there, and now Glax2013/6/14
-
Sales upside for Sanofi's Fluzone Quadrivalent looks strongThe FDA two days ago gave its approval to Sanofi's ($SNY)Fluzone Quadrivalent, a 4-in-1influenzavaccine, and now the estimates on the revenue upside are starting to roll in. GlobalData says they look2013/6/13
-
PDL, Roche duke it out over royalties for Avastin, HerceptinEven friends have disputes over money sometimes. That's what's happening withPDL BioPharmaand Roche's ($RHHBY)Genentech: PDL wants to take Genentech to arbitration for underpaying royalties, theAPrepo2013/6/13